Blue Spirulina: Benefits, Evidence, and Safety

What is blue spirulina?

Blue spirulina is not simply whole green spirulina with a different color. Products commonly use a blue, phycocyanin-rich extract made from Arthrospira platensis. FDA describes spirulina extract as a filtered aqueous extract of dried Arthrospira platensis biomass whose principal coloring components are phycocyanins.

The distinction controls what evidence applies. A trial using whole spirulina biomass does not automatically prove a benefit for a purified blue extract, and a study of one standardized phycocyanin material does not verify every retail powder.

Blue extract and whole spirulina are different study materials

What human research actually measured

A 2016 randomized, double-blind, placebo-controlled study enrolled 24 adults and tested 2.3 g/day of a phycocyanin-enriched aqueous cyanophyta extract for two weeks. The amount was described as equivalent to about 1 g of phycocyanin per day. Selected platelet-activation and clotting-time markers did not change versus placebo.

That study is useful for a narrow short-term safety question. It is not proof that blue spirulina improves immunity, energy, cognition, weight, pain, liver function, or athletic performance. The sample was small, the intervention lasted two weeks, and the tested extract cannot be assumed to match an unstandardized retail powder.

Trials of whole spirulina in people with multiple sclerosis, ulcerative colitis, or overweight use different materials and clinical populations. Their findings should remain attached to those products, doses, conditions, and outcomes.

What are the main safety questions?

For blue-green algae products, contamination control matters as much as the front-label ingredient name. FDA explains that microcystins cannot be seen, smelled, or tasted and can damage the liver and kidneys at significant exposure. FDA has described testing water and harvested material, testing each lot, using validated methods, and supplying a certificate of analysis as useful controls.

FDA's cited US survey focused on Aphanizomenon flos-aquae products, not every Arthrospira extract. That difference matters, but it does not remove the need for identity and contaminant testing in a concentrated blue powder.

Short-term tolerability in 24 adults does not settle pregnancy, breastfeeding, childhood use, chronic disease, uncommon allergy, or interactions with medicines. A reaction after use should be reported to the manufacturer and FDA's adverse-event system.

How to compare blue spirulina powders

• Identity: Arthrospira platensis should be named rather than only blue algae.
• Extract amount: read the grams or milligrams per serving.
• Phycocyanin: prefer a quantified amount or percentage over color claims.
• Lot match: the report should identify the current batch.
• Contaminants: look for microcystins, heavy metals, and microbiology.
• Scope: a raw-material report does not prove the finished package was tested.

Blue color is not a potency test. A product can look intensely blue without giving the buyer a verified phycocyanin amount or a current lot-specific contaminant result.

The evidence-based conclusion

Blue spirulina is best understood as a phycocyanin-rich color ingredient with limited direct human evidence. The most useful buying information is not a long benefit list; it is a precise identity, quantified phycocyanin, and a current contaminant report tied to the lot.

For another antioxidant-rich powder category where labels vary sharply in quantified nutrients, see our camu camu supplement comparison.

Primary sources

• FDA: 21 CFR 73.1530 spirulina extract identity.
• FDA: Blue-Green Algae Products and Microcystins.
• Jensen et al., 2016: phycocyanin-enriched extract safety trial.
• FDA scientists, 2018: microcystin survey and method evaluation.